Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have not sold either. I can’t afford the 70% loss.
Sad to think those that average under .05 presplit are down over 70%. Pathetic!
700% would be a great start. I think we’re all ready for that to start.
I wish they’d put that money to work.
Like the rest of the pumpers Armen is relying on hope. What a joke!
Zero credibility?? Untill something changes he’s been 95% correct for a long time. I’d love to see him wrong but for now he’s NOT!
I’ll be good turbo.
You too. Don't get too wasted.
Yes. Everyone enjoy the weekend. I tried to buy the $1.95s before close. I was sold 100 @ $1.92.
Enjoy the weekend JMCK. Take care everyone. Heres to better things ahead.
Have a good weekend folks, less than a month Q report comes out.
Hopefully, this has bottomed out and it starts heading north next week.
somebody put a line in the sand on Nxpl. Just saw 5000 on the bid at 1.19 hope it holds. going a little too low for my taste.
You're welcome
Interesting. Thank you.
Could get interesting especially with a strong First Quarter 10Q.
Turbo - ASCM is a notorious shorter. THey appeared last Friday and killed the run. Now they are on top of the Bid and Ask. Thinbk that signals that they are covering.
The next couple of weeks will be something to watch.
Yes my Friend. To me it does appear as if ASCM is slowly covering their short position from last Friday's run up.
Staypuff, the conversion ratio, is around 1.49 shares of NXPL for every share of RXMD, if the merger goes through. If you take the present price of of NXPL at 1.23, and multiply it by 1.49, you are pretty close to today's RXMD price at 1.85. At this point, RXMD's share price is contingent on NXPL's share price.
Why do you say that?
Gedi what we talked about the other day, I believe sooner than later as well. Shorts are covering and that tells me they know it as well.
And if such good news why is no one buying …. There is zero faith besides 2 people on this board …
So why would anybody want to sell for under $2 at this point
That’s what I’m saying ….
Bud, I was here at sub penny and had over 5 million myself and sold it after 2 years then returned 7 years ago.
And we ALL KNOW YOU lost on your last sell. So try spewing your BS to some rookie that hasn't been here from the beginning like me.
Cool story, but I haven't taken a loss here. You were not here when I loaded the boat at sub penny PPS during the days of Mrs. Mars. I held just over 4M shares selling blocks as PPS rose to over 25 cents.
Next conspiracy theory.......?
I remember his loss, then lied about it months later.
He has zero credibility.
I have not taken any losses. I have not sold.
I have been buying.
We all watched you sell for a big loss.
I see right through your BS.
So then where do you think that puts NXPL pps after the merger
700% would be a good start. The sooner the better! 🤞
$2.20 x 7 = $15.40
$2.00 x 7 = $14.00
$1.48 x 7 = $10.36
$1.40 x 7 = $9.80
$1.33 x 7 = $9.31
Good Luck RXMD shareholders!
Good Luck NXPL shareholders!
$RXMD + $NXPL
Need a lot more than 700%. That barely gets us passed pre split price
But in the end he may increase our price by 700%. You don’t know what’s in store. But we all appreciate you spending your precious time saving us from the evil Fernando
OK. I didn't realize that you think NXPL will drop below $1 and hold. Of course there is a chance. But I'm sure that the deck is stacked in NXPL's favor. I expect Q1 to be very good. I have hope again! 🤞
Why? Because I invested in Shital's technology vision and NXPL is capable of delivering it. Technology is their business.
I'm getting more shares with a lower break-even price in a bigger stronger company with a low float trading on NASDAQ. The sooner the better!
If RXMD is undervalued, RXMD + NXPL will be even more undervalued. We'll just need 1 institution to see value and we should get some movement.
IMO
Good Luck RXMD shareholders!
$RXMD + $NXPL
How could future investors be here now or before?
Sorry for your losses, Fernandez wiped out 70% of most shareholders invested. I suppose insulting those who call it as it is helps take the sting out of such a massive decline in the share price.
It does currently but doesn’t it need to keep a minimum price to stay on NASDAQ? Just curious
Are you serious? Do you understand that RXMD stock will not exist after the merger and every share of RXMD will be replaced with 1.4864864865 shares of NXPL, which trades on NASDAQ?
The combined company will have at least $70M annual revenue, very little debt, about $26M cash, and about 28M OS.
RXMD might not have been valued properly, but I'm looking forward to the merger being completed.
Good Luck RXMD shareholders!
$RXMD + $NXPL
Armen replied my LinkedIn message.
“I greatly appreciate your kind words and value your support for this company over the last 9 years. It’s been an amazing journey, and RXMD wouldn’t be where it is today without yours and all the other long-term shareholders' support. I am very grateful for that. As you probably saw in the 10-K report, the company had a strong year. Our team worked very hard and continues to do the same. As a shareholder of this company, I hope everything else will fall into the right place. ”
Actually... not that many "FUTURE" RXMD investors still here. GLTA
You're here to warn future investors??? Are you joking.
If I've said it once I've said it a hundred times he's a POS!!!
I'm not against anyone making money, but I am against a-holes that pump a stock for "YEARS" then lie about his sell orders (which we know when he did) then bash it for the next 2 years.
He has Zero Credibility and Zero integrity with over half the board.
Bottom line He's a jerk!!!
It's really sad that you show up here every day with misinformation and try to con the rookies out of their shares. You accuse Charles of being a scam, when in fact your the biggest scam.
Actually they have been making a profit as can be seen by increased cash in the bank.
And you bash while you buy and then let us all know how much you made when you flip.
Followers
|
746
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
194174
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |